KR20140024406A - 겔 침투 크로마토그래피를 이용한 바이러스의 정제방법 - Google Patents

겔 침투 크로마토그래피를 이용한 바이러스의 정제방법 Download PDF

Info

Publication number
KR20140024406A
KR20140024406A KR1020137031292A KR20137031292A KR20140024406A KR 20140024406 A KR20140024406 A KR 20140024406A KR 1020137031292 A KR1020137031292 A KR 1020137031292A KR 20137031292 A KR20137031292 A KR 20137031292A KR 20140024406 A KR20140024406 A KR 20140024406A
Authority
KR
South Korea
Prior art keywords
virus
elution buffer
gel permeation
permeation chromatography
buffered saline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020137031292A
Other languages
English (en)
Korean (ko)
Inventor
매튜 씨 코페이
앨리슨 해거만
록스나 카파디아
사라 셀
Original Assignee
온콜리틱스 바이오테크 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 온콜리틱스 바이오테크 인코포레이티드 filed Critical 온콜리틱스 바이오테크 인코포레이티드
Publication of KR20140024406A publication Critical patent/KR20140024406A/ko
Ceased legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/42Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424Elution mode
    • B01D15/426Specific type of solvent
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02Separating microorganisms from their culture media
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12051Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicinal Preparation (AREA)
KR1020137031292A 2011-04-29 2012-04-27 겔 침투 크로마토그래피를 이용한 바이러스의 정제방법 Ceased KR20140024406A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161480561P 2011-04-29 2011-04-29
US61/480,561 2011-04-29
PCT/CA2012/000406 WO2012145837A1 (en) 2011-04-29 2012-04-27 Methods of purifying viruses using gel permeation chromatography

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020197006419A Division KR102151890B1 (ko) 2011-04-29 2012-04-27 겔 침투 크로마토그래피를 이용한 바이러스의 정제방법

Publications (1)

Publication Number Publication Date
KR20140024406A true KR20140024406A (ko) 2014-02-28

Family

ID=47067091

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020137031292A Ceased KR20140024406A (ko) 2011-04-29 2012-04-27 겔 침투 크로마토그래피를 이용한 바이러스의 정제방법
KR1020197006419A Active KR102151890B1 (ko) 2011-04-29 2012-04-27 겔 침투 크로마토그래피를 이용한 바이러스의 정제방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020197006419A Active KR102151890B1 (ko) 2011-04-29 2012-04-27 겔 침투 크로마토그래피를 이용한 바이러스의 정제방법

Country Status (15)

Country Link
US (1) US20120273424A1 (https=)
EP (1) EP2702147B1 (https=)
JP (1) JP6029651B2 (https=)
KR (2) KR20140024406A (https=)
CN (1) CN103492557B (https=)
AU (1) AU2012248082B2 (https=)
CA (1) CA2832367A1 (https=)
DK (1) DK2702147T3 (https=)
EA (1) EA201391605A1 (https=)
ES (1) ES2822199T3 (https=)
IL (1) IL228491A (https=)
MX (1) MX337348B (https=)
SG (1) SG194449A1 (https=)
TW (1) TW201307561A (https=)
WO (1) WO2012145837A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011336413B2 (en) * 2010-12-02 2015-01-22 Oncolytics Biotech Inc. Liquid viral formulations
MX349294B (es) 2010-12-02 2017-07-21 Oncolytics Biotech Inc Formulaciones virales liofilizadas.
BR112015031541A2 (pt) 2013-06-17 2017-07-25 De Staat Der Nederlanden Vert Door De Mini Van Vws Miniie Van Volksgezondheid Welzijn En Sport métodos para o impedimento da agregação de componentes virais
US11999975B2 (en) 2018-07-04 2024-06-04 Probiogen Ag Method for purifying an enveloped virus
CN111812313B (zh) * 2020-06-22 2021-10-08 北京生物制品研究所有限责任公司 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法
CN114544815B (zh) * 2022-03-01 2023-10-27 中牧实业股份有限公司 一种山羊痘病毒的定量检测方法
CN116718524B (zh) * 2023-06-26 2025-11-07 西安交通大学 一种基于细胞膜色谱技术的病毒颗粒检测方法
HUP2400154A1 (hu) * 2024-02-29 2025-09-28 Pecsi Tudomanyegyetem Elúciós oldat és tisztítási eljárás

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
DE69029765T2 (de) * 1989-07-24 1997-05-15 Bayer Ag Stabilisierung von hochgereinigten Proteinen
JP3863559B2 (ja) * 1994-05-16 2006-12-27 メルク エンド カンパニー インコーポレーテッド 乳頭腫ウィルスワクチン
KR100912362B1 (ko) * 1998-02-17 2009-08-19 쉐링 코포레이션 바이러스 제제의 정제방법
DK2253701T3 (da) 2001-03-16 2014-10-20 Oncolytics Biotech Inc Fremgangsmåde til ekstraktion af en virus fra en cellekultur
CA2482512C (en) * 2002-04-30 2011-09-20 Oncolytics Biotech Inc. Improved viral purification methods
US7901921B2 (en) * 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
EP1878791A1 (en) * 2006-07-11 2008-01-16 Bia Separations D.O.O. Method for influenza virus purification
EP2055311B1 (en) * 2006-08-07 2017-06-21 The Chemo-Sero-Therapeutic Research Institute Process for preparing live smallpox vaccine
JP5577103B2 (ja) * 2007-03-12 2014-08-20 オンコリティクス バイオテク,インコーポレーテッド 改変配列を有するレオウイルス
NZ585500A (en) * 2007-11-12 2012-06-29 Theraclone Sciences Inc Antibodies which bind to an epitope in the extracellular domain of the matrix 2 ectodomain polypeptide of an influenza virus
US8227577B2 (en) * 2007-12-21 2012-07-24 Hoffman-La Roche Inc. Bivalent, bispecific antibodies
MX349294B (es) * 2010-12-02 2017-07-21 Oncolytics Biotech Inc Formulaciones virales liofilizadas.
AU2011336413B2 (en) * 2010-12-02 2015-01-22 Oncolytics Biotech Inc. Liquid viral formulations

Also Published As

Publication number Publication date
KR20190026059A (ko) 2019-03-12
MX2013012627A (es) 2014-05-13
JP2014516515A (ja) 2014-07-17
KR102151890B1 (ko) 2020-09-03
IL228491A (en) 2017-05-29
EP2702147B1 (en) 2020-07-15
SG194449A1 (en) 2013-12-30
AU2012248082A1 (en) 2013-05-09
IL228491A0 (en) 2013-12-31
AU2012248082B2 (en) 2015-08-20
WO2012145837A1 (en) 2012-11-01
CN103492557A (zh) 2014-01-01
ES2822199T3 (es) 2021-04-29
MX337348B (es) 2016-02-29
US20120273424A1 (en) 2012-11-01
EA201391605A1 (ru) 2014-02-28
EP2702147A1 (en) 2014-03-05
EP2702147A4 (en) 2014-11-05
CN103492557B (zh) 2015-07-29
TW201307561A (zh) 2013-02-16
CA2832367A1 (en) 2012-11-01
DK2702147T3 (da) 2020-09-28
JP6029651B2 (ja) 2016-11-24

Similar Documents

Publication Publication Date Title
KR102151890B1 (ko) 겔 침투 크로마토그래피를 이용한 바이러스의 정제방법
CA2584142C (en) Improved viral purification methods
EP1501921B1 (en) Improved viral purification methods
Li et al. A hydrophobic interaction chromatography strategy for purification of inactivated foot-and-mouth disease virus
JP6433954B2 (ja) 凍結乾燥されたウイルス製剤
WO2000023104A1 (en) Freeze-dried hepatitis a attenuated live vaccine and its stabilizer
Krajacic et al. Application of monolithic chromatographic supports in virus research
JP2004520841A (ja) 細胞培養物からウイルスを抽出する方法
JP2014502275A (ja) 液体ウイルス製剤
CN103041399A (zh) 一种耐热保护剂及其应用
HK1190431B (en) Methods of purifying viruses using gel permeation chromatography
HK1190431A (en) Methods of purifying viruses using gel permeation chromatography
US20250346868A1 (en) Viral Extraction from Cell Culture
Ganesh EFFECT OF IONIC LIQUIDS ON THE RECOVERY AND STABILITY OF INACTIVATED FOOT AND MOUTH DISEASE VIRUS SEROTYPE ASIA1
CN102430125A (zh) 用于鸡胚液冻干的耐热保护剂、其制备方法及其应用
CN121443316A (zh) 用于免疫原性组合物的稳定剂组合物、稳定的免疫原性组合物、其方法和应用
Wei Development of metal-affinity partitioning of Hepatitis B core antigen from unclarified bacteria feedstock
CN107164334A (zh) 一种猪圆环病毒繁殖培养基及其应用
HK1070670B (en) Improved viral purification methods

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20131126

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20170425

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20180330

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20181026

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20180330

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20181026

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20180530

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20170425

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20181227

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20181128

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20181026

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20180530

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20180330

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20170425

X601 Decision of rejection after re-examination
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20190304